Showing posts with label dolutegravir. Show all posts
Showing posts with label dolutegravir. Show all posts

Tuesday 26 November 2013

ViiV's HIV Drug Recommended for EU Approval


ViiV's HIV Drug Recommended for EU Approval 

read all

here

Thumbnail
ViiV Healthcare, the HIV company established by GlaxoSmithKline and Pfizer in 2009, announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has recommended marketing authorization for Tivicay (dolutegravir) for use in combination with other antiretroviral medicinal products for the treatment of HIV-infected patients. How soon could the drug be approved in the EU? Find out...